These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 2206410)

  • 41. Progress in the control of measles in Ghana, 1980-2000.
    Bosu WK; Essel-Ahun M; Adjei S; Strebel P
    J Infect Dis; 2003 May; 187 Suppl 1():S44-50. PubMed ID: 12721890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Appropriate age for measles vaccination in the United States.
    Orenstein WA; Markowitz L; Preblud SR; Hinman AR; Tomasi A; Bart KJ
    Dev Biol Stand; 1986; 65():13-21. PubMed ID: 3549395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measles eradication in the Americas: progress to date.
    de Quadros CA; Izurieta H; Venczel L; Carrasco P
    J Infect Dis; 2004 May; 189 Suppl 1():S227-35. PubMed ID: 15106116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monitoring vaccine safety during measles mass immunization campaigns: clinical and programmatic issues.
    Pless RP; Bentsi-Enchill AD; Duclos P
    J Infect Dis; 2003 May; 187 Suppl 1():S291-8. PubMed ID: 12721928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility of global measles eradication after interruption of transmission in the Americas.
    de Quadros CA; Andrus JK; Danovaro-Holliday MC; Castillo-Solórzano C
    Expert Rev Vaccines; 2008 Apr; 7(3):355-62. PubMed ID: 18393605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunization against measles by aerosol.
    Sabin AB
    Rev Infect Dis; 1983; 5(3):514-23. PubMed ID: 6348918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Review of the effect of measles vaccination on the epidemiology of SSPE.
    Campbell H; Andrews N; Brown KE; Miller E
    Int J Epidemiol; 2007 Dec; 36(6):1334-48. PubMed ID: 18037676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experience in global measles control, 1990-2001.
    Henao-Restrepo AM; Strebel P; John Hoekstra E; Birmingham M; Bilous J
    J Infect Dis; 2003 May; 187 Suppl 1():S15-21. PubMed ID: 12721887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
    Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H
    Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progress toward measles eradication in the region of the Americas.
    De Quadros CA; Izurieta H; Carrasco P; Brana M; Tambini G
    J Infect Dis; 2003 May; 187 Suppl 1():S102-10. PubMed ID: 12721900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Late vaccination reinforcement during a measles epidemic in Niamey, Niger (2003-2004).
    Dubray C; Gervelmeyer A; Djibo A; Jeanne I; Fermon F; Soulier MH; Grais RF; Guerin PJ
    Vaccine; 2006 May; 24(18):3984-9. PubMed ID: 16540214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Measles epidemiology and elimination strategies in Turkey.
    Güriş D; Bayazit Y; Ozdemirer U; Buyurgan V; Yalniz C; Toprak I; Aycan S
    J Infect Dis; 2003 May; 187 Suppl 1():S230-4. PubMed ID: 12721918
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Early reactions in pupils vaccinated with an aerosol measles vaccine].
    Fernández Bracho JG; Roldán Fernández SG
    Salud Publica Mex; 1990; 32(6):653-7. PubMed ID: 2089641
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren.
    Bennett JV; Fernandez de Castro J; Valdespino-Gomez JL; Garcia-Garcia Mde L; Islas-Romero R; Echaniz-Aviles G; Jimenez-Corona A; Sepulveda-Amor J
    Bull World Health Organ; 2002; 80(10):806-12. PubMed ID: 12471401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measles aerosol vaccination.
    Valdespino-Gómez JL; de Lourdes Garcia-Garcia M; Fernandez-de-Castro J; Henao-Restrepo AM; Bennett J; Sepulveda-Amor J
    Curr Top Microbiol Immunol; 2006; 304():165-93. PubMed ID: 16989270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Basic indices of measles incidence in the years of mass inoculations with live measles vaccine].
    Shul'ga OE; Siniak KM
    Vrach Delo; 1979 May; (5):103-7. PubMed ID: 452582
    [No Abstract]   [Full Text] [Related]  

  • 58. [Measles morbidity against a background of mass vaccinal prophylaxis in Kara-Su District, Osh Province].
    Nurakhunov NN
    Zdravookhr Kirg; 1978; (1):27-31. PubMed ID: 24934
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparative Estimates of Crude and Effective Coverage of Measles Immunization in Low-Resource Settings: Findings from Salud Mesoamérica 2015.
    Colson KE; Zúñiga-Brenes P; Ríos-Zertuche D; Conde-Glez CJ; Gagnier MC; Palmisano E; Ranganathan D; Usmanova G; Salvatierra B; Nazar A; Tristao I; Sanchez Monin E; Anderson BW; Haakenstad A; Murphy T; Lim S; Hernandez B; Lozano R; Iriarte E; Mokdad AH
    PLoS One; 2015; 10(7):e0130697. PubMed ID: 26136239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Current problems in the epidemiology and prevention of measles in the Ukrainian SSR. Reasons for the unfavorable epidemic situation with respect to measles which developed during the years of planned immunization].
    Merenkova AM; Tsipershteĭn MIa
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Aug; (8):100-5. PubMed ID: 7445862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.